Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/1995
06/28/1995EP0659185A1 Novel isoindolinone derivative, its preparation and pharmaceutical compositions containing same
06/28/1995EP0659183A1 Heteroaryl compounds used as pharmaceuticals
06/28/1995EP0659174A1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
06/28/1995EP0659172A1 Analogues of vpa used as anti-epileptica.
06/28/1995EP0659083A1 Prevention and treatment of peripheral neuropathy
06/28/1995EP0659078A1 Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system
06/28/1995EP0659073A1 Biodegradable polymer matrices for sustained delivery of local anesthetic agents
06/28/1995EP0580644B1 1,3,4-trisubstituted piperidine derivatives, their production and use
06/28/1995EP0521067B1 Azacyclic or azabicyclic compounds, their preparation and use
06/28/1995CN1104096A Snake-poison substitute medicine for giving up drug-taking and curing senile dementia and its preparation method
06/27/1995US5428169 Pharmaceutically useful (3-phenyl-1H-pyrazolo[4,3-C]pyridin-1-yl)-acetonitrile
06/27/1995US5428164 Certain 4-aryl substituted piperazinyl and piperidinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
06/27/1995US5428158 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/27/1995US5428069 Treating cognition with, aminocyclopropanecarboxylic derivatives
06/27/1995US5428065 1,3-benzenedimethanamines useful as central nervous system active agents
06/27/1995US5428053 Treats alzheimer's disease and other senile dementias
06/27/1995US5428042 1-(2H-1-oxo-3,4-dihydronaphtyl-6-yl)-acetyl-piperidines as kappa agonists
06/27/1995US5428038 Benzopyranones, a method for producing them and uses therefor
06/27/1995US5428037 Heterocyclic derivatives in the treatment of Ischaemia and related diseases
06/27/1995US5428036 Psychological disorders
06/27/1995US5427798 Controlled sustained release tablets containing bupropion
06/27/1995CA2035805C Tricyclic-cyclic amines as novel cholinesterase inhibitors
06/27/1995CA1336071C Pharmaceutical composition for systemic transdermal administration
06/25/1995CA2138745A1 2-phenyl-7-azabicycloheptanes and 6 phenyl-8-azabicyclooctanes
06/22/1995WO1995016684A1 3-substituted 1-arylindole compounds
06/22/1995WO1995016683A1 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
06/22/1995WO1995016679A1 Morpholine and thiomorpholine tachykinin receptor antagonists
06/22/1995WO1995016674A1 Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
06/22/1995WO1995016672A1 Vitamin d amine and amide derivatives
06/22/1995WO1995016663A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
06/22/1995WO1995016466A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995WO1995016450A1 Use of pentoxifyllin in the treatment of multiple sclerosis
06/22/1995WO1995016448A1 Paroxetine tablets and process to prepare them
06/22/1995WO1995016443A1 Di-tert-butylphenol compounds useful as anti-inflammatory agents
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995CA2274387A1 Paroxetine tablets and process to prepare them
06/22/1995CA2179203A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
06/22/1995CA2179179A1 3-substituted 1-arylindole compounds
06/22/1995CA2179168A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995CA2179009A1 Di-tert-butylphenol compounds useful as anti-inflammatory agents
06/22/1995CA2178090A1 Vitamin d amine and amide derivatives
06/22/1995CA2176848A1 Use of pentoxifyllin in the treatment of multiple sclerosis
06/22/1995CA2138638A1 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
06/22/1995CA2138505A1 Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
06/22/1995CA2138499A1 Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome
06/22/1995CA2138495A1 Methods of inhibiting alzheimer's disease
06/22/1995CA2138459A1 Methods of inhibiting cns problems in post-menopausal women
06/22/1995CA2138458A1 Methods of inhibiting obsessive-compulsive and consumptive disorders
06/22/1995CA2138457A1 Non-peptide tachykinin receptor antagonists
06/22/1995CA2138100A1 Methods of treating menstrual symptoms and compositions therefor
06/21/1995EP0658559A1 Thienothiazin derivatives, process for their preparation and their use as 5-dipoxygenase and cyclooxygenase inhibitors
06/21/1995EP0658557A1 Eburnane derivatives, processes for their preparation and pharmaceutical compositions containing them
06/21/1995EP0658546A1 Novel 3-pyrazolecarboxamide derivatives with cannabinoid receptor affinity
06/21/1995EP0658545A1 Decahydro-isoquinoline derivatives
06/21/1995EP0658539A1 Excitatory amino acid receptor antagonists
06/21/1995EP0658538A1 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
06/21/1995EP0658347A2 Pharmaceutical composition, containing diclofenac and 2-hydroxypropyl-beta-cyclodextrin
06/21/1995EP0658160A1 Antipsychotic quinoline derivatives of benzodioxanmethylamine
06/21/1995EP0658157A1 Diaryl piperazinoacetamide compounds as antimuscarinic agents
06/21/1995CN1104018A Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and use anti-eptic, neuroprotective and antidepressant agents
06/21/1995CN1104017A Substituted (arylalkoxybenzyl) aminopropanamide derivatives, their preparation and use as anti-epileptic, neuroprotective and antidepressant agents
06/20/1995US5426229 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes
06/20/1995US5426226 Intermediates for making ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
06/20/1995US5426186 Diagnosis, treatment of anxiety, sleep and seizure disorders, benzodiazepine overdose; enhancement of alertness
06/20/1995US5426122 Methods for reducing blood pressure with dimercaptosuccinic acid (DMSA)
06/20/1995US5426103 Certain macrocyclic lactam derivatives
06/20/1995CA1336004C Phenethanolamine derivatives
06/20/1995CA1336001C Arylalkoxycoumarins, their preparation and therapeutic agents containing these compounds
06/20/1995CA1335999C Phenethanolamine derivatives
06/20/1995CA1335996C 2-substituted carbonylimidazo¬4,5-c|quinolines
06/15/1995WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
06/15/1995WO1995015979A1 Pretargeting methods and compounds
06/15/1995WO1995015961A1 Bicyclic heterocycles as neurokinin a antagonists
06/15/1995WO1995015954A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists
06/15/1995WO1995015953A1 Novel substituted oxazolidines
06/15/1995WO1995015948A1 Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
06/15/1995WO1995015756A1 Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors
06/15/1995WO1995015755A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent
06/15/1995WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995WO1995009619A3 Substituted urea and isothiourea derivatives as no synthase inhibitors
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2177840A1 Cs-1 peptidomimetics, compositions and methods of using the same
06/15/1995CA2177739A1 Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
06/15/1995CA2177495A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/15/1995CA2175701A1 Bicyclic heterocycles as neurokinin a antagonists
06/15/1995CA2137976A1 Thienothiazine derivatives
06/14/1995EP0657468A1 Human stromae derived factor
06/14/1995EP0657459A1 Thienothiazine derivates, process for their preparation and their use as anti-inflammatory and analgesic agents
06/14/1995EP0657458A1 Protein kinase C inhibitors
06/14/1995EP0657456A1 Process for preparing epibatidine
06/14/1995EP0657455A1 Epi-epibatidine derivatives, a process and intermediates for preparing them and epi-epibatidine and medicaments containing the epi-epibatidine derivatives and/or epi-epibatidine and the use of them
06/14/1995EP0657454A1 Imidazopyridazines being angiotensin II antagonists
06/14/1995EP0657443A1 Optically active carboxamide derivative
06/14/1995EP0657440A1 Oxazolidine-2-one derivatives
06/14/1995EP0657434A1 Arylsubstituted -alkoxy-1,4-dihydropyridin-5-carbonic acid esters with cerebral activity
06/14/1995EP0657433A1 Dihydropyridines with substituted esters showing cerebral activity
06/14/1995EP0657432A1 Phenyl-substituted 1,4-dihydropyridines with cerebral activity
06/14/1995EP0657431A1 4-Phenyl-3-substituted 1,4-dihydropyridine esters with cerebral activity
06/14/1995EP0657430A1 Isopropyl-(2-methoxyethyl)-4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-piridine-3,5-dicarboxylate
1 ... 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 ... 1833